AAArmin Attaranzadeh

Armin Attaranzadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Armin Attaranzadeh has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Alpha‐Lipoic Acid on Glyphosate‐Treated Human Granulosa Cells: A Cross‐Sectional Study

    by Sakineh Kaboli Kafshgiri, Armin Attaranzadeh, Hossein Safarpour, Fahimeh Ghasemi, Ebrahim Miri‐Moghaddam

    Backgrounds and Aims: An association between Glyphosate (GLY) exposure and a higher frequency of miscarriage and preterm birth has been shown. To evaluate the effects of alpha‐lipoic acid (ALA) on folliculogenesis gene expression and oxidative stress in human GLY‐treated granulosa cells (GCs). Methods: GCs were obtained from 46 healthy women who had tubal or male infertility factors. The GCs were cultured and treated with GLY (250 μg mL −1 ), ALA (50 μg mL − 1 ), or 250 GLY + 50 ALA for 24 h. The effect of ALA on apoptosis was evaluated using DAPI staining and flow cytometry. We assessed the expression of several genes in treated GCs using real‐time PCR. We looked at the Forkhead box protein O1 ( FOXO1 ), NADPH oxidase 4 ( NOX4 ), Vanin‐1 ( VNN1 ), and steroidogenic acute regulatory protein ( StAR ) genes. Additionally, we examined antioxidant genes, including glutathione peroxidase ( GPX ), catalase ( CAT ), and superoxide dismutase ( SOD ). Results: DNA fragmentation was less pronounced in the ALA‐treated and GLY + ALA groups compared to the GLY‐treated group. ALA treatment reduced the apoptotic ratio in GLY treatment and the combination of GLY + ALA (5.5% and 19.6% vs. 35.8%), respectively. GLY reduced the fold expression of CAT , GPX , and SOD by 0.27, 0.24, and 0.44, respectively. In the ALA treatment group, the fold expression of SOD , CAT , and GPX exceeded that in the untreated group (1.2, 1.02, and 1.7, respectively). GLY decreased the expression of the VNN1 and StAR genes while increasing the expression of the FOXO1 and NOX4 genes compared to the control group. Furthermore, ALA decreased FOXO1 and NOX4 expression in GCs and increased VNN1 and StAR gene expression. Conclusion: Exposure to GLY induced apoptosis, and ALA increased the expression of antioxidant genes in GCs. Additionally, ALA can be recommended to reduce the damage caused by oxidants to the female reproductive system.


  • Open Access

    Sustanon suppresses spermatogenesis and increases cell death

    by Fatemeh Kamali Hosseinzadeh, Jina Khayatzadeh, Mohammad Mahdi Forghanifard, Armin Attaranzadeh

    Background: Anabolic-androgenic steroids (AAS) are synthetic derivatives of testosterone. Sustanon, dissolved in peanut oil, is an AAS used by athletes to build muscle mass. This study aims to examine the effects of Sustanon on male reproductive health. Methods: Adult male rats were divided into four groups under standard conditions. The control group received an intramuscular injection of the Sustanon solvent. The second, third, and fourth groups were treated with different doses (10, 20, and 30 mg/kg body weight) of Sustanon for 8 weeks. Blood samples, testes, and spermatozoa were collected for laboratory tests. Complementary DNA (cDNA) was synthesized from total RNA, and the expression of deleted in azoospermia like (DAZL) and B-cell lymphoma 2 (BCL2) genes was measured by real-time polymerase chain reaction (PCR). Histopathological analysis was performed on the testes. Results: The BCL2 gene had significantly lower expression in the treatment groups compared to the control group. There was no significant increase in the expression of DAZL. Significant reductions in testicular length, diameter, weight, sperm count, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) concentrations were observed in the treatment groups. Histological changes were evident in the testes of the treated groups. Conclusions: Sustanon likely induces adverse effects on the male reproductive system, potentially decreasing fertility. The study provides critical insights into the negative impacts of Sustanon on spermatogenesis and cell survival.


  • Use of artificial intelligence–based digital pathology to predict outcomes for immune checkpoint inhibitor therapy in advanced gastro-esophageal cancer.

    by Feyisope Eweje, Zhe Li, Matthew Gopaulchan, Armin Attaranzadeh, Leon Kloker, Yuming Jiang, Maximilian Diehn, Guoxin Li, Ruijiang Li

    4013 Background: Accurate prediction of response and survival outcomes with anti-PD-1/PD-L1 immune checkpoint inhibition (ICI) remains a significant challenge in gastro-esophageal cancers. In this study, we use an artificial intelligence (AI)-based single-cell analysis of digitized whole-slide H&E images (WSIs) to predict objective response and survival benefit of ICI in two independent cohorts of gastro-esophageal cancer patients. Methods: WSIs were obtained from 82 ICI-treated advanced gastroesophageal cancer patients (gastric, esophageal, and gastro-esophageal junction adenocarcinoma and squamous cell carcinoma) at Stanford University for discovery, and 189 ICI-treated advanced gastric adenocarcinoma patients at Southern Medical University for external validation. Deep learning models were deployed for automated tumor area detection and segmentation of cell nuclei within WSIs. We developed a fully automated cell annotation approach by leveraging multiplex immunofluorescence and trained a deep learning model to classify nuclei into four cell types from H&E (tumor cells, lymphocytes, neutrophils, and macrophages). A total of 66 features were computed to quantify cell composition and cell-cell interactions within the tumor microenvironment. Treatment outcomes were assessed using progression-free survival (PFS) and best objective response per the Response Evaluation Criteria in Solid Tumors (v1.1), with statistical significance reported at the 95% confidence level. Results: In the training cohort, a spatial feature characterizing lymphocyte and neutrophil interaction had the strongest association with PFS (hazard ratio = 0.44, 95% CI 0.24-0.79, P = 0.0046). In the validation cohort, the spatial biomarker positive population had significantly improved PFS compared to the spatial biomarker negative population (hazard ratio = 0.41, 95% CI 0.27-0.61, P < 0.0001; median time to event: 19 months vs 9 months). For predicting objective response in the validation cohort, a multivariate model combining the spatial features achieved AUROC = 0.81 compared to AUROC = 0.65 for PD-L1 CPS (P = 0.0014), while combining the multivariate model with PD-L1 CPS achieved AUROC = 0.84. Conclusions: A single-cell computational pathology approachidentifies spatial biomarkers with predictive utility for determining ICI treatment outcomes in advanced gastro-esophageal cancer. Further validation of these findings is being pursued in additional cohorts.


  • Open Access

    Evaluation of cytokine levels as possible predicting elements in patients with chronic lymphocytic leukemia

    by Maryam Khodashenas, Arezoo Rajabian, Armin Attaranzadeh, Fahimeh Lavi Arab, Negin Allahyari, Abolghasem Allahyari

    This study aimed to assess the patterns of serum cytokines in chronic lymphocytic leukemia patients at baseline and post-chemotherapy and investigate their association with response to treatment and chronic lymphocytic leukemia prognosis. Blood samples were taken from 32 subjects at their first medical visit after being diagnosed with chronic lymphocytic leukemia and 1 year after chemotherapy. Then, levels of cytokines and blood parameters in peripheral blood were measured. Correlation analysis was used to assess the indexes before and after chemotherapy as well as at different disease stages. Most of the patients (45.80%) had stages I and III before initiation of treatment and after treatment, respectively. There were significant differences between levels of interleukin (IL)-6 (p=0.006) and IL-10 (p=0.009) before and after treatment. Notably, the difference in IL-10 levels before and after treatment was significantly higher in the advanced stages compared to that in the non-advanced stages (p=0.007). IL-6 and IL-10 were also higher in the expired patients compared to the survived cases. Cytokines such as IL-6 and IL-10 may be considered predicting factors for chronic lymphocytic leukemia prognosis.


  • Formulation and evaluation of anticancer and antiangiogenesis efficiency of PLA–PEG nanoparticles loaded with galbanic acid in C26 colon carcinoma, in vitro and in vivo

    by Maryam Afsharzadeh, Khalil Abnous, Rezvan Yazdian–Robati, Armin Ataranzadeh, Mohammad Ramezani, Maryam Hashemi

    Galbanic acid (GBA) is an active sesquiterpene coumarin derivative, with various medicinal benefits, including anticancer properties. However, the low solubility of GBA is the main limitation of its clinical applications. In this study, we used a nanosystem based on poly (D, l‐lactide)–polyethylene glycol (PLA–PEG), for the delivery of GBA to C26 colon carcinoma cells. The physicochemical characteristics of nanoparticles (NPs) prepared by the emulsification–evaporation method were evaluated. MTT assay was used to compare the anticell proliferation of GBA and PLA–PEG–GBA against C26 cell lines. PLA–PEG‐NPs with an average size of about 140 nm had an enhanced release of GBA at a pH of 5.5 compared with a pH of 7.4. Cytotoxicity studies showed that the IC 50 of the PLA–PEG–GBA NPs (8 µM) was significantly lower than free GBA (15 µM). In the in vivo study, PLA–PEG–GBA NPs exhibited remarkable efficacy and reduced in vivo toxicity in C26 colon carcinoma tumor‐bearing female BALB/c mice. To study the antiangiogenesis effect of the NPs, tumor sections were stained with an anti CD34 antibody. The results show the CD34 (+) vessels were decreased in the GBA and PLA–PEG–GBA treated mice by more than 75% and 90%, respectively. These results suggest that the encapsulation of GBA into the PLA–PEG could potentially be used for the treatment of colorectal cancer.